Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Oncology CRO for clinical drug research expertise in all cancers
Hematology and Oncology Clinical Research

Hematology and Oncology CRO for Clinical Research

Medpace has the medical leadership, hematology/oncology-trained operational staff, global trial experience and site relationships to give our clients the competitive advantage in the ever-evolving landscape of hematology and oncology development. Medpace is the hematology/oncology CRO that helps our clients:

  • Develop successful strategies, for even the most novel therapies
  • Plan and conduct effective studies
  • Compete successfully for high-performing global sites
  • Expedite study start-up and recruitment

Deep and Broad Hematology and Oncology Experience

  • Full range of solid tumor and hematologic indications and therapies from classic multi-cytotoxic agents to cutting-edge and targeted therapies
  • Small, focused trials to large global studies

The Medpace Difference for Hematology and Oncology Studies

In addition to the Medpace Difference that applies to all of our therapeutic areas, our oncology and hematology clients benefit from:
  • Oncology medical experts who provide strategic, educational and practical leadership
  • Required hematology/oncology training for all operational staff, regardless of therapeutic focus
  • Long-term relationships with successful, experienced sites and preferred CRO status with key Phase I oncology centers
  • Integrated tumor imaging and central laboratory services, ensuring seamless logistics, review and testing